AKT1 and prostate cancer: Lamoureux et al. also reported that the autophagy inhibitor chloroquine cooperates with the Akt inhibitor AZD5363 to inhibit autophagy, and sensitizes tumor cells to AZD5363-induced cell death in prostate cancer models [46].